Aim and Scope

The International Journal of AI EBioMedicine Innovations (IJ-AIEBI) aims to serve as a premier platform for advancing the integration of artificial intelligence, biomedical engineering, and healthcare innovations. The journal seeks to connect researchers, clinicians, engineers, data scientists, and healthcare professionals in fostering transformative solutions that improve patient care, accelerate drug discovery, and enhance clinical decision-making.

Objectives

IJ-AIEBI is committed to:

  1. Promoting Interdisciplinary Research – Bridging AI technologies with life sciences, clinical practice, and biomedical engineering.

  2. Advancing Precision Medicine – Showcasing AI-driven tools for diagnostics, prognostics, and personalized therapies.

  3. Encouraging Digital Health Innovations – Supporting work on wearables, telemedicine, remote monitoring, and smart healthcare systems.

  4. Accelerating Drug Discovery & Development – Publishing cutting-edge methods that use AI to design, test, and optimize new therapeutics.

  5. Enhancing Biomedical Imaging & Diagnostics – Advancing AI applications in radiology, pathology, and imaging sciences.

  6. Supporting Ethical & Responsible AI – Exploring the ethical, societal, and regulatory aspects of deploying AI in medicine.

  7. Global Accessibility – Ensuring open-access research that benefits both developed and developing healthcare ecosystems.

Scope

The journal covers, but is not limited to, the following areas:

  • Machine Learning & Deep Learning in healthcare

  • Bioinformatics & Computational Biology

  • Biomedical Imaging & Computer Vision

  • AI in Drug Design, Genomics, and Proteomics

  • Robotics and Smart Medical Devices

  • Health Data Science & Big Data Analytics

  • Digital Health, Wearables, and Remote Monitoring

  • AI in Surgery, Rehabilitation, and Patient Care

  • Ethics, Policy, and Legal Issues in AI-driven Biomedicine